《Chinese Journal of Rehabilitation Theory and Practice》 ›› 2023, Vol. 29 ›› Issue (10): 1221-1226.doi: 10.3969/j.issn.1006-9771.2023.10.015

Previous Articles     Next Articles

Association of serum adiponectin and high sensitivity C-reactive protein levels to short-term outcome in patients with acute ischemic stroke

ZHANG Chunlong1,2a, LIU Fuliang3, SHANG Na1,2b, LI Fang1,2c, LIU Huizhen1,2b()   

  1. 1. Capital Medical University School of Rehabilitation Medicine, Beijing 100068, China
    2a. Department of Geriatric Medicine (General Rehabilitation Medicine); b. Department of Emergency Medicine; c. Department of Neurology, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing 100068, China
    3. Department of Emergency Medicine, Shandong Juxian People's Hospital, Rizhao, Shandong 276500, China
  • Received:2022-10-26 Revised:2023-06-19 Published:2023-10-25 Online:2023-11-16
  • Contact: LIU Huizhen, E-mail: liuhuizhen0513@126.com
  • Supported by:
    Youth Foundation of China Rehabilitation Research Center(2018zx-Q6);Open Project of Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation(2020XFN-KFKT-01)

Abstract:

Objective To study the association of serum adiponectin and high sensitivity C-reactive protein (hs-CRP) levels to short-term outcome in patients with acute ischemic stroke (AIS).
Methods Clinical data of 216 patients with AIS in Beijing Bo'ai Hospital from January, 2019 to September, 2020 were collected. The serum biochemical indicator was measured in all the patients within 24 hours after enrollment, and adiponectin was detected with enzyme-linked immunosorbent assay. Meanwhile, all patients were evaluated with National Institute of Health Stroke Scale (NIHSS). Modified Rankin Scale (mRS) was used to assess the functional outcome 90 days after onset during follow-up.
Results The incidence of poor outcome in patients with AIS within 90 days was 48.1%. Compared with the good outcome group, the serum adiponectin was lower (t = 5.861, P < 0.001) and the serum hs-CRP level was higher (Z = 5.525, P < 0.001) poor outcome group. Reduced serum adiponectin (OR = 0.862, 95%CI 0.751 to 0.975, P < 0.001) and increased serum hs-CRP (OR = 1.215, 95%CI 1.015 to 1.455, P < 0.001) were independent risk factors for poor outcome in patients with AIS. The areas under curve (95% CI) of serum adiponectin and hs-CRP for predicting the outcome of patients with AIS were 0.819 (0.761 to 0.877) and 0.722 (0.654 to 0.791), respectively (P < 0.001). The predictive power of serum adiponectin was higher than that of hs-CRP (Z = 2.151, P = 0.032). The optimum cut-off point of adiponectin was < 3.5 mg/L, and the Yoden index was 0.609, yielding a sensitivity of 0.704 and a specificity of 0.905.
Conclusion Serum adiponectin and hs-CRP can serve as independent predictors for short functional outcome in patients with AIS.

Key words: acute ischemic stroke, adiponectin, high sensitivity C-reactive protein, short-term outcome, association

CLC Number: